Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ornithine Phenylacetate in Cirrhosis and Upper GI Bleeding
NCT01434108Phase 3Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Oct 2011
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ornithine phenylacetate in hyperammonemia, hepatic encephalopathy (HE), sponsored by Vall d'Hebron Research Institute. Started Oct 2011; status: completed.
02
Drugs
ornithine phenylacetate
03
Conditions
hyperammonemiahepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01434108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01434108.